Na/K-ATPase Reduction in Renal Disease-Related Cardiac Dysfunction
肾病相关心脏功能障碍中 Na/K-ATP 酶的减少
基本信息
- 批准号:8966030
- 负责人:
- 金额:$ 37.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-15 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:AgeAllelesAngiotensin II ReceptorAngiotensin-Converting Enzyme InhibitorsAnimal ModelAnimalsAntibodiesApoptosisAttenuatedBlood PressureBlood specimenCardiacCardiac GlycosidesCardiovascular systemCell DeathCell SurvivalCellsCessation of lifeChronic Kidney FailureComplexCouplesDataDeteriorationDigibindDilated CardiomyopathyFunctional disorderGenderGenesGeneticGoalsGrowthHeartHumanIn VitroKidneyKidney DiseasesKidney FailureLeadLeft ventricular structureLinkMeasuresMembraneMethodsMusMuscle CellsMyocardial dysfunctionNa(+)-K(+)-Exchanging ATPaseNephrectomyNeutralization TestsOperative Surgical ProceduresOutcomePathway interactionsPatientsPeptidesPharmaceutical PreparationsProcessRandomized Controlled Clinical TrialsReceptor Protein-Tyrosine KinasesRenal functionRenin-Angiotensin SystemRoleSignal PathwaySignal TransductionTestingTimeTissuesTransgenic MiceUnited States National Institutes of HealthValidationWorkadjudicateattenuationheart functionhuman studyin vivoknock-downmarinobufageninmouse modelnew therapeutic targetpro-apoptotic proteinprotein expressionrenal ischemiaresearch studyresponsetooluremic cardiomyopathy
项目摘要
DESCRIPTION (provided by applicant): Chronic renal disease (CKD) is closely related with poor cardiovascular outcomes. Our recent experimental data indicate that Na/K-ATPase reduction may be related with renal insufficiency-induced cardiac dysfunction. First, we have observed that 5/6th partial nephrectomy (PNx) induces a time-dependent decrease of Na/K-ATPase in the mouse heart along with maladaptive cardiac remodeling and deterioration in heart function. The left ventricle initially shows hypertrophic growth and then dilation, which correlates with changes in Na/K-ATPase expression. Second, we have new evidence demonstrating that reduction in Na/K-ATPase potentiates cardiotonic steroid (CTS)-induced cardiac cell death in vitro, and dilated cardiomyopathy in vivo. In transgenic mice, genetic reduction of Na/K-ATPase stimulates the expression of pro-apoptotic proteins and potentiates CTS-induced cardiac cell death. It also causes decreased contractile function in these mice. Third, our data have revealed that in normal cardiac cells there exists a self-protection mechanism preserving the membrane abundance of Na/K-ATPase and protecting cells from death. Reduction of Na/K-ATPase attenuates the signaling function that is related with this self-protection. Furthermore, our work demonstrates that endogenous CTS are elevated in animals and humans with renal diseases. These studies lead us to hypothesize that reduction of Na/K-ATPase together with a sustained increase in CTS potentiates myocyte apoptosis and results in cardiac dysfunctions in renal insufficiency. To test this hypothesis we will conduct experiments in a well established PNx animal model, and use transgenic mice and newly developed tools to assess the pathways that are related with myocyte death. In parallel, we will perform the human study to link renal function and CTS release to cardiac dysfunction.
描述(由申请人提供):慢性肾脏疾病(CKD)与不良心血管结局密切相关。我们最近的实验数据表明,Na/K-ATP酶减少可能与肾功能不全引起的心功能不全有关。首先,我们已经观察到,5/6肾部分切除术(PNx)诱导小鼠心脏Na/K-ATP酶的时间依赖性降低沿着适应不良的心脏重塑和心功能恶化。左心室最初显示肥厚性生长,然后扩张,这与Na/K-ATP酶表达的变化相关。其次,我们有新的证据表明,Na/K-ATP酶的减少增强了强心类固醇(CTS)诱导的体外心脏细胞死亡和体内扩张型心肌病。在转基因小鼠中,Na/K-ATP酶的遗传减少刺激促凋亡蛋白的表达并增强CTS诱导的心脏细胞死亡。它还导致这些小鼠的收缩功能下降。第三,我们的数据表明,在正常的心肌细胞中,存在着一种自我保护机制,保护膜Na/K-ATP酶的丰度,保护细胞免于死亡。Na/K-ATP酶的减少减弱了与这种自我保护相关的信号传导功能。此外,我们的工作表明,内源性CTS在患有肾脏疾病的动物和人类中升高。这些研究使我们推测Na/K-ATP酶的减少与CTS的持续增加一起增强心肌细胞凋亡并导致肾功能不全时的心脏功能障碍。 为了验证这一假设,我们将在一个完善的PNx动物模型中进行实验,并使用转基因小鼠和新开发的工具来评估与肌细胞死亡相关的途径。同时,我们将进行人体研究,以将肾功能和CTS释放与心功能不全联系起来。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease.
循环 CD40 和 sCD40L 可预测慢性肾病患者肾功能的变化。
- DOI:10.1038/s41598-017-08426-8
- 发表时间:2017
- 期刊:
- 影响因子:4.6
- 作者:Xie,JeffreyX;Alderson,Helen;Ritchie,James;Kalra,PhilipA;Xie,Yanmei;Ren,Kaili;Nguyen,Hanh;Chen,Tian;Brewster,Pamela;Gupta,Rajesh;Dworkin,LanceD;Malhotra,Deepak;Cooper,ChristopherJ;Tian,Jiang;Haller,StevenT
- 通讯作者:Haller,StevenT
Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.
- DOI:10.4172/2329-6607.1000204
- 发表时间:2017-01-01
- 期刊:
- 影响因子:0
- 作者:Fan, X;Xie, J;Tian, J
- 通讯作者:Tian, J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiang Tian其他文献
Jiang Tian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiang Tian', 18)}}的其他基金
Na/K-ATPase Reduction in Renal Disease-Related Cardiac Dysfunction
肾病相关心脏功能障碍中 Na/K-ATP 酶的减少
- 批准号:
8236333 - 财政年份:2011
- 资助金额:
$ 37.45万 - 项目类别:
Na/K-ATPase Reduction in Renal Disease-Related Cardiac Dysfunction
肾病相关心脏功能障碍中 Na/K-ATP 酶的减少
- 批准号:
8578103 - 财政年份:2011
- 资助金额:
$ 37.45万 - 项目类别:
Na/K-ATPase Reduction in Renal Disease-Related Cardiac Dysfunction
肾病相关心脏功能障碍中 Na/K-ATP 酶的减少
- 批准号:
8773604 - 财政年份:2011
- 资助金额:
$ 37.45万 - 项目类别:
Na/K-ATPase Reduction in Renal Disease-Related Cardiac Dysfunction
肾病相关心脏功能障碍中 Na/K-ATP 酶的减少
- 批准号:
8399057 - 财政年份:2011
- 资助金额:
$ 37.45万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:














{{item.name}}会员




